About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Another Nature stem cell paper is retracted

with one comment

nature 73014Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.

According to that 2010 news story:

The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.

But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Read the rest of this entry »

About these ads

MD Anderson postdoc faked results of Novartis anti-cancer compound study

with 16 comments

jun fu

Raymond Sawaya, director of MD Anderson’s brain tumor program, presents Jun Fu with the 2014 Caroline Ross Endowment Fellowship.

A former postdoc at MD Anderson Cancer Center faked the results of a mouse study of a Novartis compound designed to fight brain tumors, according to the Office of Research Integrity (ORI).

Jun Fu “admitted to knowingly and intentionally falsifying Figure 8a” in “Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor–Initiating Cells,” a paper published in Cancer Research on May 15, 2013: Read the rest of this entry »

Written by Ivan Oransky

August 1, 2014 at 8:00 am

Article about alcohol withdrawal withdrawn

with 2 comments

A stumble in data preparation earned a retraction for a paper on delirium tremensalcohol_and_alcoholism, a life-threatening side effect of alcohol withdrawal that spans a wide range of symptoms, including hallucinations and seizures.

Though the initial retraction notice was extremely unhelpful, the author stepped in to give us a better picture of the errors that led to the paper’s demise.

Here’s the notice from Alcohol and Alcoholism about “Biochemical Predictors of Delirium Tremens in Patients in Alcohol Withdrawal”:

Read the rest of this entry »

UT-Southwestern cancer research group notches ninth retraction

with one comment

lung cancerA research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.

Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Read the rest of this entry »

Authors retract paper “confirming” that narcolepsy is an autoimmune disease

with 5 comments

stmA group of researchers at Stanford and elsewhere is retracting a 2013 paper that another scientist told Nature was “one of the biggest things to happen in the narcolepsy field for some time.”

The Science Translational Medicine paper caused a buzz because it claimed to show that narcolepsy was an autoimmune disease. Here’s the notice: Read the rest of this entry »

Mega-correction appears for Florida leadership scholar Walumbwa following six retractions

with 3 comments

Fred Walumbwa, via FIU

Fred Walumbwa, via FIU

Fred Walumbwa, the leadership researcher at Florida International University who has retracted six papers for what appear to be problematic data, now has an impressive mega-correction in the form of an “addendum.”

The paper, “Relationships between Authentic Leadership, Moral Courage, and Ethical and Pro-Social Behaviors,” was published in Business Ethics Quarterly in October 2011, by Walumbwa and two colleagues, Sean Hannah and Bruce Avolio.

Here’s the abstract for the paper, which has been cited 18 times, according to Thomson Scientific’s Web of Knowledge:

Read the rest of this entry »

Written by amarcus41

July 30, 2014 at 11:00 am

Bitter rheumatology authorship dispute ends in retraction

with 3 comments

rbrA 2012 expression of concern prompted by an authorship dispute has been upgraded to a retraction.

As we reported in 2012, Revista Brasiliera de Reumatologia (aka the Brazilian Journal of Rheumatology) issued an expression of concern about “Anticitrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection” after

a claim from one of the authors, questioning the authorship of the corresponding author, and informed that the article was under submission to another journal.

The journal sought the advice of the Committee on Publication Ethics (COPE), and continued its investigation. That investigation is apparently now complete, and this retraction notice is the result: Read the rest of this entry »

Follow

Get every new post delivered to your Inbox.

Join 33,900 other followers